BR9815219A - Use of thiazolidinediones for the treatment of hyperglycemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycemia

Info

Publication number
BR9815219A
BR9815219A BR9815219-0A BR9815219A BR9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A
Authority
BR
Brazil
Prior art keywords
treatment
hyperglycemia
thiazolidinediones
thiazolidinedions
mammal
Prior art date
Application number
BR9815219-0A
Other languages
Portuguese (pt)
Inventor
Robin Edwing Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9815219A publication Critical patent/BR9815219A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"USO DE TIAZOLIDINEDIONAS PARA O TRATAMENTO DA HIPERGLICEMIA" A presente invenção refere-se a um método para o tratamento da hiperglicemia onde os níveis plasmáticos de glicose na faixa de normal a elevada para <243>126 mg/dl, cujo método compreende a administração de uma quantidade eficaz, não-tóxica e farmaceuticamente aceitável de um sensibilizador da insulina, para um mamífero que necessite do tratamento."USE OF THIAZOLIDINEDIONS FOR THE TREATMENT OF HYPERGLYCEMIA" The present invention relates to a method for the treatment of hyperglycemia where plasma glucose levels in the range from normal to elevated to <243> 126 mg / dl, the method of which comprises administration of an effective, non-toxic and pharmaceutically acceptable amount of an insulin sensitizer, for a mammal in need of treatment.

BR9815219-0A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycemia BR9815219A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
BR9815219A true BR9815219A (en) 2001-01-02

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815219-0A BR9815219A (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (en) * 1987-09-04 1999-12-15 Beecham Group Plc SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVES
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
JP2001519382A (en) 2001-10-23
IL135513A0 (en) 2001-05-20
OA11683A (en) 2005-01-12
AU9547098A (en) 1999-05-03
CN1281359A (en) 2001-01-24
HUP0003922A3 (en) 2001-12-28
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
WO1999018943A1 (en) 1999-04-22
EA200000419A1 (en) 2000-10-30
CA2306086A1 (en) 1999-04-22
BG104404A (en) 2000-12-29
YU28800A (en) 2003-02-28
CZ20001297A3 (en) 2001-08-15
KR20010024481A (en) 2001-03-26
NZ503862A (en) 2003-01-31
EP1023056A1 (en) 2000-08-02
PL339813A1 (en) 2001-01-02
NO20001898L (en) 2000-06-09
TR200000958T2 (en) 2000-08-21
ID24521A (en) 2000-07-20
EA002659B1 (en) 2002-08-29
SK5312000A3 (en) 2000-09-12
NO20001898D0 (en) 2000-04-12
HUP0003922A2 (en) 2001-10-28
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
BR9911656A (en) Pharmaceutical composition, processes for the prevention or treatment of diabetes in a mammal, for the prevention or treatment of diabetic complications in a mammal and for the prevention or treatment of impaired glucose tolerance in a mammal, use of an insulin sensitizer, and, process to reduce the side effects of an insulin sensitizer or / and an anoretic administered to a diabetic mammal
NO20090846L (en) Combination and pharmaceutical composition for the treatment of diabetes and its use
NO994706L (en) Pharmaceutical composition for oral administration of an N-piperidino-3-pyrazole carboxyamide derivative, as well as salts and solvates thereof
KR960000924A (en) Insulin analogue combination
YU37301A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
BR9911112A (en) Glucagon-like petpìdeo-1 improves ß-cell response to glucose in patients with impaired glucose tolerance
NO944803L (en) Controlled release pharmaceutical preparation
BR9808888A (en) Dosage forms and method of improving male erectile dysfunction
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
BR9810445A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and diguanide
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
CY1107745T1 (en) TREATMENT OF DIABETES WITH THIAZOLIDINODION AND SULFONYLURIA
BR9810444A (en) Treatment of diabetes with rosiglitazone and insulin
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
ES2196167T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING PROPIONATE 3- (2,2,2-TRIMETHYL HYDRAZINY) AND GAMMA-BUTIROBETAIN FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
BR9809673A (en) Triptolide derivatives useful in the treatment of autoimmune diseases
US6589995B2 (en) Method of inhibiting pancreatic β-cell p135 O-glycosylation
BR9810292A (en) Diabetes treatment with thiazolidinedione, insulin secretagogue and alpha-glucosidase inhibitor
BR9810186A (en) Diabetes treatment with thiazolidinedione and alpha-glycosity inhibitor
BR9815220A (en) Use of thiazolidinediones for the treatment of hyperglycemia
BR9815219A (en) Use of thiazolidinediones for the treatment of hyperglycemia
AU8019898A (en) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome
AR039162A1 (en) VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION
BR9915214A (en) Combinations containing a beta-agonist and an additional anti-diabetic agent
AR008025A1 (en) PHARMACEUTICAL COMBINATION OF A THIAZOLIDINDIONA AND AN INSULIN SECRETOGOGUE

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.